Immune Analysis Using Vitreous Optical Coherence Tomography Imaging in Rats with Steroid-Induced Glaucoma

Rodrigo, Maria J. (Universidad de Zaragoza) ; Subías, Manuel (Universidad de Zaragoza) ; Montolío, Alberto ; Martínez-Rincón, Teresa (Universidad de Zaragoza) ; Aragón-Navas, Alba ; Bravo-Osuna, Irene ; Pablo, Luis E. (Universidad de Zaragoza) ; Cegoñino, Jose ; Herrero-Vanrell, Rocío ; Garcia-Martin, Elena (Universidad de Zaragoza) ; Pérez del Palomar, Amaya

Resumen: Glaucoma is a multifactorial pathology involving the immune system. The subclinical immune response plays a homeostatic role in healthy situations, but in pathological situations, it produces imbalances. Optical coherence tomography detects immune cells in the vitreous as hyperreflective opacities and these are subsequently characterised by computational analysis. This study monitors the changes in immunity in the vitreous in two steroid-induced glaucoma (SIG) animal models created with drug delivery systems (microspheres loaded with dexamethasone and dexamethasone/fibronectin), comparing both sexes and healthy controls over six months. SIG eyes tended to present greater intensity and a higher number of vitreous opacities (p < 0.05), with dynamic fluctuations in the percentage of isolated cells (10 µm2), non-activated cells (10–50 µm2), activated cells (50–250 µm2) and cell complexes (>250 µm2). Both SIG models presented an anti-inflammatory profile, with non-activated cells being the largest population in this study. However, smaller opacities (isolated cells) seemed to be the first responder to noxa since they were the most rounded (recruitment), coinciding with peak intraocular pressure increase, and showed the highest mean Intensity (intracellular machinery), even in the contralateral eye, and a major change in orientation (motility). Studying the features of hyperreflective opacities in the vitreous using OCT could be a useful biomarker of glaucoma.

Idioma: Inglés

DOI: 10.3390/biomedicines12030633

Año: 2024

Publicado en: Biomedicines 12, 3 (2024), 20 pp.
ISSN: 2227-9059

Financiación: info:eu-repo/grantAgreement/ES/MCIU/MAT2017-83858-C2-2
Financiación: info:eu-repo/grantAgreement/ES/MCIN/AEI/10.13039/501100011033
Financiación: info:eu-repo/grantAgreement/ES/MICINN/MAT2017-83858-C2-1
Financiación: info:eu-repo/grantAgreement/ES/MICINN/MAT2017-83858-C2-2
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PID2020-113281RB-C22
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PRE2018-083951
Financiación: info:eu-repo/grantAgreement/ES/MINECO/MAT2017-83858-C2-1
Financiación: info:eu-repo/grantAgreement/ES/MINECO/MAT2017-83858-C2-2
Financiación: info:eu-repo/grantAgreement/ES/NextGenerationEU/PRTR

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Obstetricia y Ginecología (Dpto. Cirugía)
Área (Departamento): Área Oftalmología (Dpto. Cirugía)